Quoin Pharmaceuticals, Ltd. (QNRX) has 13 open-market insider trades by 6 insiders since 2024. Over the last six months insiders net bought $280K. The most active filer is Michael Myers, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Michael Myers | CEO | — | 3 | $629K | 2026-08-31 |
| Denise P. Carter | COO | — | 3 | $629K | 2026-08-31 |
| Dennis Langer | Dir | — | 2 | $257K | 2026-08-27 |
| Gordon Dunn | CFO | — | 2 | $133K | 2024-12-23 |
| Anthony James Culverwell | Dir | — | 2 | $75K | 2026-08-31 |
| Sally Bridget Lawlor | CFO | — | 1 | $50K | 2026-08-31 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael Myers | CEO | Buy | $100K | 2026-08-31 |
| Anthony James Culverwell | Director | Buy | $30K | 2026-08-31 |
| Sally Bridget Lawlor | CFO | Buy | $50K | 2026-08-31 |
| Dennis Langer | Director | Buy | $257K | 2025-10-14 |
| Michael Myers | CEO | Buy | $500K | 2024-12-23 |
| Anthony James Culverwell | Director | Buy | $45K | 2024-12-23 |
Companies that share insiders with QNRX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Gordon Dunn | CFO | Buy | $110K | 2024-12-23 |
| Gordon Dunn | CFO | Buy | $23K | 2024-09-09 |
| Denise P. Carter | COO | Buy | $29K | 2024-09-03 |
| Michael Myers | CEO | Buy | $29K | 2024-09-03 |
| Dennis Langer | Director | Sell | $217 | 2024-06-07 |